The latest price target for Zivo Bioscience (OTCQB:ZIVO) was reported by Maxim Group on June 4, 2024. The analyst firm set a price target for $0.00 expecting ZIVO to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.

The latest analyst rating for Zivo Bioscience (OTCQB:ZIVO) was provided by Maxim Group, and Zivo Bioscience downgraded their hold rating.

There is no last upgrade for Zivo Bioscience

The last downgrade for Zivo Bioscience Inc happened on June 4, 2024 when Maxim Group changed their price target from N/A to N/A for Zivo Bioscience Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Zivo Bioscience, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Zivo Bioscience was filed on June 4, 2024 so you should expect the next rating to be made available sometime around June 4, 2025.

While ratings are subjective and will change, the latest Zivo Bioscience (ZIVO) rating was a downgraded with a price target of $0.00 to $0.00. The current price Zivo Bioscience (ZIVO) is trading at is $21.50, which is out of the analyst’s predicted range.